Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis — Stella

Recruiting

Back to Adolescent Asthma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Key details

Phase

Safety & dosing

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Enrollment target

~252 participants

Started

January 2025

Primary completion

November 2027

Age range

18 Years – 75 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov